Author Correction: Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
Nat Cancer
.
2022 Oct;3(10):1271.
doi: 10.1038/s43018-022-00458-y.
Authors
Su Deng
#
1
,
Choushi Wang
#
1
,
Yunguan Wang
#
2
,
Yaru Xu
1
,
Xiaoling Li
1
,
Nickolas A Johnson
1
,
Atreyi Mukherji
1
,
U-Ging Lo
3
,
Lingfan Xu
4
,
Julisa Gonzalez
1
,
Lauren A Metang
1
,
Jianfeng Ye
5
,
Carla Rodriguez Tirado
1
,
Kathia Rodarte
6
,
Yinglu Zhou
4
,
Zhiqun Xie
2
,
Carlos Arana
7
,
Valli Annamalai
1
,
Xihui Liu
3
,
Donald J Vander Griend
8
,
Douglas Strand
3
,
Jer-Tsong Hsieh
3
,
Bo Li
5
,
Ganesh Raj
3
,
Tao Wang
2
,
Ping Mu
9
10
11
Affiliations
1
Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA.
2
Quantitative Biomedical Research Center, Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA.
3
Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA.
4
Department of Pathology, Duke University School of Medicine, Durham, NC, USA.
5
Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.
6
Department of Neuroscience, UT Southwestern Medical Center, Dallas, TX, USA.
7
Wakeland Genomics Core, UT Southwestern Medical Center, Dallas, TX, USA.
8
Department of Pathology, The University of Illinois at Chicago, Chicago, IL, USA.
9
Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX, USA. ping.mu@utsouthwestern.edu.
10
Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center, Dallas, TX, USA. ping.mu@utsouthwestern.edu.
11
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. ping.mu@utsouthwestern.edu.
#
Contributed equally.
PMID:
36241729
PMCID:
PMC9586863
DOI:
10.1038/s43018-022-00458-y
No abstract available
Publication types
Published Erratum
Grants and funding
RR170079/Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)
17YOUN12/Prostate Cancer Foundation (PCF)
T32C124334/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
RP220473/Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)
1P30CA142543/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
R01CA178431/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
W81XWH-16-1-0474/U.S. Department of Defense (United States Department of Defense)
1R01CA245318/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
1R37CA258730/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
Endowed Scholar/University of Texas Southwestern Medical Center (UT Southwestern)
R37 CA258730/CA/NCI NIH HHS/United States
1R01CA258584/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
W81XWH21-1-0520/U.S. Department of Defense (United States Department of Defense)
5R00CA218885/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
W81XWH2110418/U.S. Department of Defense (United States Department of Defense)
RR170050/Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)
RP190208/Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)
W81XWH18-1-0411/U.S. Department of Defense (United States Department of Defense)
RP160157/Cancer Prevention and Research Institute of Texas (Cancer Prevention Research Institute of Texas)
I-2005-20190330/Welch Foundation
Cancer Center Pilot/University of Texas Southwestern Medical Center (UT Southwestern)